Sodium Butyrate

Short-Chain Fatty Acid Salt

Sodium salt of butyric acid used experimentally and sold as a supplement. The retained studies concern mouse or rat disease models, not controlled human efficacy or supplement pharmacokinetics.

Pharmacokinetic model

A route-level PK model for sodium butyrate is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.

Key facts

Category
Short-Chain Fatty Acid Salt
Suggested cadence
once daily

Research behind this entry

  1. Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning Henagan TM, Stefanska B, Fang Z, Navard AM, Ye J, Lenard NR, Devarshi PP · British Journal of Pharmacology, 2015 DOI

    Mouse high-fat-diet experiment reported metabolic and epigenetic changes after sodium butyrate. It does not establish weight-loss or insulin- sensitivity benefits in humans.

  2. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A · Journal of Alzheimer's Disease, 2011 DOI

    Mouse Alzheimer-model study reported memory changes with sodium butyrate. It is preclinical and does not show prevention or treatment of human dementia.

2 published studies referenced in the app, each with a plain-language summary.